ALEXZA PHARMA (NASDAQ:ALXA)
2.28
+0.06 (2.70%)
| ALEXZA PHARMA (NASDAQ:ALXA) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $2.22 | 52 Week High | $3.53 | ||
| Open | $2.23 | 52 Week Low | $1.16 | ||
| Day High | $2.28 | P/E | N/A | ||
| Day Low | $2.19 | EPS | $-2.75 | ||
| Volume | 29,842 | ||||
| More ALXA Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| SLXP | 3 | SURG | 2 |
| EMKR | 2 | VOXW | 2 |
| ANCI | 2 | HDY | 2 |
| KERX | 2 | LZB | 2 |
| AHT | 2 | ALC | 1 |
| COMV | 1 | GBG | 1 |
Entities who have mentioned ALXA
- Piper Jaffray | View Related Stories »
- RBC Capital | View Related Stories »
- Robert W Baird | View Related Stories »
- Needham & Co | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- 13G | View Related Stories »
- Wedbush Morgan | View Related Stories »
- Notable Mergers and Acquisitions | View Related Stories »
- Citi | View Related Stories »
- Merrill Lynch | View Related Stories »
- Banc of America | View Related Stories »
- JMP Securities | View Related Stories »
- HSBC | View Related Stories »
- Trading Radar | View Related Stories »
- Dividend | View Related Stories »
View All ReportsStreetInsider.com Reports on ALXA
- Alexza Pharmaceuticals (ALXA) Reports Large Q3 Loss
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- Alexza (ALXA) Selling 8.1M Shares At $2.4325 A Share
- Unusual 11 Mid-Day Movers 9/14: ZOOM, SLXP, BRNC, HDY Higher; AMIE, ALXA, ALTI, CDE Lower
- Morning Movers 9/14: SLXP, S, KERX, ARIA, HDY Higher; ALXA, EE, SAH, CWTR Lower
View All Press ReleasesCompany Press Releases on ALXA
- Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
- Alexza Reports 2009 Third Quarter Financial Results and Updates AZ-004 (Staccato(R) Loxapine) NDA Status
- Alexza to Announce 2009 Third Quarter Financial Results and Update Its AZ-004 NDA Status on Monday, November 9, 2009
- Alexza Pharmaceuticals to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
- Alexza to Raise $19.7 Million in Private Placement
StreetInsider Reports on ALXA by Category
View All BlogsBlogs on ALXA
- Transcept Pharma Loses Sleep over Insomnia Drug Approval
- Closing Update: Stocks Manage Narrowly Higher Finish
- Extreme FDA Trades: Another 18 Stocks Under 5 Bucks
- Three Top and Bottom Market Sectors for This Week
- Aradigm: Hard to Value, But Significant Upside
View All FilingsSEC Filings on ALXA
- Form 8-K Alexza Pharmaceuticals For: Nov 09
- Form 10-Q Alexza Pharmaceuticals For: Sep 30
- Form 4 Simms Michael J For: Oct 30
- Form 4 Moretti August J For: Oct 30
- Form 8-K Alexza Pharmaceuticals For: Nov 02
Comments on ALXA
No comments are currently available.
